Merrimack Pharmaceuticals, Inc. (MACK) financial statements (2020 and earlier)

Company profile

Business Address ONE BROADWAY
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:17719322186124155
Cash and cash equivalents172093221863665
Short-term investments 51   8890
Other undisclosed cash, cash equivalents, and short-term investments00    (0)
Restricted cash and investments 100000
Receivables  017636
Inventory, net of allowances, customer advances and progress billings   154 
Inventory   154  
Other undisclosed current assets2414555
Total current assets:19769557201132167
Noncurrent Assets
Property, plant and equipment 2616221513
Long-term investments and receivables 711    
Long-term investments 711    
Intangible assets, net (including goodwill)   8111112
Goodwill   4444
Intangible assets, net (excluding goodwill)   4788
Restricted cash and investments  11111
Other noncurrent assets1350000
Total noncurrent assets:1122224332726
TOTAL ASSETS:208911781235159192
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3141850523739
Accounts payable0133532
Accrued liabilities026161417 
Employee-related liabilities 239967
Taxes payable 0     
Interest and dividends payable  0233 
Other undisclosed accounts payable and accrued liabilities2862021830
Debt     138
Deferred rent credit 1
Deferred revenue and credits238526111
Other liabilities0      
Total current liabilities:315208810411158
Noncurrent Liabilities
Long-term debt and lease obligation 15 217258107103
Long-term debt, excluding current maturities 15 217258107103
Liabilities, other than long-term debt 0129564173
Deferred revenue and credits129564173
Other liabilities 00    
Other undisclosed noncurrent liabilities    122
Total noncurrent liabilities: 151246315150178
Total liabilities:33021334419261236
Stockholders' equity
Stockholders' equity attributable to parent175996(251)(184)(102)(43)
Common stock1111111
Additional paid in capital557581578702617552528
Accumulated other comprehensive loss (0)   (0)(0)
Accumulated deficit(541)(523)(483)(955)(802)(655)(572)
Stockholders' equity attributable to noncontrolling interest   (2)00 
Other undisclosed stockholders' equity      0
Total stockholders' equity:175996(253)(184)(102)(43)
TOTAL LIABILITIES AND EQUITY:208911781235159192

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues5 21448910348
Revenue, net 14489  
Gain on disposition of assets for financial service operations5 
Financial services revenue2    
Cost of revenue   (7)(0)  
Gross profit:5 21378910348
Operating expenses(22)(66)(105)(248)(219)(169)(170)
Other undisclosed operating income (loss)(5) 8  02
Operating loss:(22)(66)(96)(110)(130)(66)(121)
Nonoperating income (expense)(0)(3)100111
Investment income, nonoperating11120000
Other nonoperating income (expense)0(3)(1)(0)111
Interest and debt expense(1)(1)(35)(44)(19)(18)(11)
Loss from continuing operations before equity method investments, income taxes:(24)(69)(120)(154)(148)(84)(131)
Other undisclosed income from continuing operations before income taxes112    
Loss from continuing operations before income taxes:(23)(68)(118)(154)(148)(84)(131)
Income tax benefit1842    
Loss from continuing operations:(21)(61)(76)(154)(148)(84)(131)
Income from discontinued operations420547    
Net income (loss):(17)(41)471(154)(148)(84)(131)
Net income (loss) attributable to noncontrolling interest  12(0)0(0)
Net income (loss) available to common stockholders, diluted:(17)(41)472(152)(148)(83)(131)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(17)(41)471(154)(148)(84)(131)
Comprehensive income (loss):(17)(41)471(154)(148)(84)(131)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest  12(0)00
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)  0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(17)(41)472(152)(148)(83)(131)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: